Published in:
01-02-2013 | Clinical Investigation
Extrahepatic Pseudoaneurysms and Ruptures of the Hepatic Artery in Liver Transplant Recipients: Endovascular Management and a New Iatrogenic Etiology
Authors:
Wael E. A. Saad, Niloy Dasgupta, Allison J. Lippert, Ulku C. Turba, Mark G. Davies, Sean Kumer, Jason C. Gardenier, Saher S. Sabri, Auh-Whan Park, David L. Waldman, Timothy Schmitt, Alan H. Matsumoto, John F. Angle
Published in:
CardioVascular and Interventional Radiology
|
Issue 1/2013
Login to get access
Abstract
Purpose
To characterize extrahepatic pseudoaneurysm regarding incidence and etiology and determine the effectiveness of endovascular management.
Methods
A retrospective audit of 1,857 liver transplants in two institutions was performed (1996–2009). Recipients’ demographics, clinical presentation, transplant type, biliary anastomosis, and presence of biliary endoprostheses were noted. Pseudoaneurysms were classified into iatrogenic (associated with biliary endoprosthesis or angioplasty) or spontaneous extrahepatic pseudoaneurysms. Spontaneous and iatrogenic pseudoaneurysms were compared for time from transplant, presenting symptoms, location in the arterial anatomy, and 3-month graft survival. Arterial patency and 6-month graft survival were calculated.
Results
Twenty pseudoaneurysms were found (1.1 %, 20/1,857): 9 (0.5 % of transplants, 9/1,857) were spontaneous and 11 (0.6 % of transplants, 11/1,857) were “iatrogenic” (due to minimally invasive procedures: 4 angioplasty and 7 biliary endoprostheses). Sixty percent (12/20) underwent endovascular management (4 coil embolization and 8 stent-grafts). Technical success was 83 % (10/12) with a mean arterial patency of 70 % (follow-up mean, 4.9; range, 0–18 months). The 1-, 3-, and 6-month graft survival was 70, 40, and 35 %, respectively.
Conclusions
Due to minimally invasive procedures, posttransplant extrahepatic pseudoaneurysms are no longer an exclusive complication of the transplant surgery itself. Endovascular management is effective to stabilize patients but has not improved historic postsurgical graft survival.